West Paces Advisors Inc. Horizon Therapeutics Public LTD CO Transaction History

West Paces Advisors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 18, 2023	BUY	$58.92 - $84.67 $11,312 - $16,256	192 Added 45.61%	613 $37.9 Million
Q2 2022 Dec 18, 2023	BUY	$79.4 - $116.36 $14,689 - $21,526	185 Added 78.39%	421 $33.6 Million
Q1 2022 Dec 18, 2023	BUY	$86.42 - $109.81 $20,395 - $25,915	236 New	236 $24.8 Million
Q4 2021 Dec 19, 2023	BUY	$98.56 - $119.91 $2,266 - $2,757	23 Added 10.8%	236 $25.4 Million
Q2 2021 Dec 19, 2023	BUY	$86.24 - $95.92 $18,369 - $20,430	213 New	213 $19.9 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on West Paces Advisors Inc. with notifications on news.